SABS - SAB Biotherapeutics, Inc.

📈 Is growth accelerating? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	-62.4% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-880%)	—	207.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+2496%)	62.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+682%)	-85.9% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1174%)	-64.7% Weak ↑ Weak Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-909%)	-98.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1333%)	-95.1% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1288%)	-80.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1106%)	-75.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1044%)	-65.1% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-914%)	-30.3% Weak Weak Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-478%)	—	—	—	—	—	—
EPS Growth YoY (%)	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	58.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	-38.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	-3.7% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	68.1% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-12.0% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	43.6% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	64.0% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	5.2% Fair → Fair Stable Year-over-year change in earnings per share Optimal: > 10%	37.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-27.3% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	1.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution ↑ Caution Improving Year-over-year change in earnings per share Optimal: > 10%	0.0% Caution Caution Year-over-year change in earnings per share Optimal: > 10%	-60.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—
Net Income Growth YoY (%)	-263.1% Weak ↓ Weak Declining Year-over-year change in net income	-48.0% Weak ↓ Weak Declining Year-over-year change in net income	-3.4% Weak ↓ Weak Declining Year-over-year change in net income	-3.4% Weak ↓ Weak Declining Year-over-year change in net income	-3.4% Weak ↓ Weak Declining Year-over-year change in net income	50.1% Excellent ↑ Excellent Improving Year-over-year change in net income	31.7% Excellent ↑ Excellent Improving Year-over-year change in net income	31.7% Excellent ↑ Excellent Improving Year-over-year change in net income	31.7% Excellent Excellent Year-over-year change in net income	-190.3% Weak Weak Year-over-year change in net income	N/M	N/M	N/M	31.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-30.1% Weak → Weak Stable Year-over-year change in net income	-30.1% Weak Weak Year-over-year change in net income	-30.1% Weak Weak Year-over-year change in net income	—	—	—	—	—	—
FCF Growth YoY (%)	66.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	28.7% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-264.6% Weak Weak Year-over-year change in free cash flow	—	—	—	88.1% Excellent Excellent Year-over-year change in free cash flow	—	—	—	N/M	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	-78.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	—	-75.6% Weak Weak Compound annual revenue growth over 3 years	-61.8% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	-420.0% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2900%)	—	—	-363.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2525%)	-217.5% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1550%)	-103.0% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-787%)	-56.8% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-479%)	-66.4% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-543%)	-27.2% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-281%)	-15.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-205%)	4.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-68%)	—	—
Effective Tax Rate (%) (%)	—	—	—	—	—	—	—	—	—	—	—	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	1.9% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	8.6% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	—	—	—	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	-364.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-3137%)	27.5% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+129%)	15.5% Good ↑ Good Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+29%)	8.4% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-30%)	-104.5% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-971%)	9.6% Caution ↑ Caution Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-20%)	7.7% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-35%)	8.3% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-31%)	—	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	-280.0% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-77.4% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	-98.7% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-65.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	3.9% Weak ↑ Weak Improving Free cash flow as a percentage of revenue Optimal: > 10%	-54.1% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	44.7% Excellent Excellent Free cash flow as a percentage of revenue Optimal: > 10%	—	—
FCF / Net Income (x)	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.99x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.51x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.38x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	1.50x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.84x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	2.16x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.22x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.21x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	-11.82x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.63x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.40x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	-6.99x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	5.36x Excellent Excellent Free cash flow relative to reported net income Optimal: > 1x	—	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-7.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.1% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-64.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-39.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-24.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.5% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-17.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-26.0% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-27.6% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-32.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-30.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-20.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-17.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.9% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-15.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.0% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-5.9% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	1.6% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	—	—
Return on Capital (%) (%)	-8.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-9.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-6.9% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-32.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-28.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-22.6% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-21.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-22.5% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-18.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-17.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-15.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-14.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-11.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-9.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-9.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—	—
Return on Common Equity (%) (%)	-8.3% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-155%)	-11.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-174%)	-3.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-121%)	-43.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-388%)	-24.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-262%)	-43.9% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-393%)	-13.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-10.9% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-173%)	-9.5% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-163%)	-39.9% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-366%)	-48.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-421%)	-37.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-349%)	-30.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-301%)	-25.4% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-269%)	3.2% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-79%)	2.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-82%)	2.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-84%)	-30.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-300%)	4.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-73%)	3.7% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-75%)	3.5% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-77%)	—	—

⚖️ Is the balance sheet risky? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Interest Coverage (x)	-317.49x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-247.57x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-291.32x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-150.19x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-153.86x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-141.68x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	—	-109.56x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-149.15x Weak → Weak Stable Operating income divided by interest expense Optimal: > 5x	-284.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-76.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-85.99x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-80.12x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-89.62x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-110.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-91.85x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-93.13x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-110.81x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-50.80x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-38.59x Weak Weak Operating income divided by interest expense Optimal: > 5x	10.82x Excellent Excellent Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-20.52M	$-10.50M	$-29.42M	$-3.69M	$-5.64M	$-8.90M	$-9.17M	$-17.24M	$-14.03M	$-56.57M	$-2.43M	$-7.77M	$-13.06M	$-15.05M	$-8.33M	$-16.62M	$-22.41M	$-33.21M	$-10.75M	$-10.23M	$-20.13M	$-12.61M	—

📊 What does each share earn? 6 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	—	—	—	—	—	—	—	$0.03	$0.10	—	$0.24	$0.02	$0.12	—	$0.83	$1.48	$2.74	—	$5.65	$7.01	$6.52	—	—
Basic EPS, GAAP (USD)	$-0.35	$-0.51	$0.50	$-1.09	$-0.56	$-1.23	$-1.12	$-0.79	$-0.54	$-3.85	$-1.00	$-1.40	$-1.50	$-4.06	$-1.60	$-1.10	$0.20	$-4.10	$-1.60	$-1.10	$0.50	—	—
Free Cash Flow per Share (USD)	$-0.28	—	$-1.22	$-0.77	$-0.84	—	—	—	$-1.18	—	—	—	$-0.32	—	—	—	$-2.70	—	$0.22	$-3.79	$2.91	—	—
Book Value per Share (USD)	$3.00	$3.18	$3.48	$1.29	$2.30	$2.80	$4.00	$5.00	$5.72	$6.21	$2.92	$3.77	$4.84	$6.16	$7.12	$8.63	$9.60	$8.86	$13.51	$14.73	$15.70	$15.02	—
Tangible Book Value per Share (USD)	$3.00	$3.18	$3.48	$1.29	$2.30	$2.80	$4.00	$5.00	$5.72	$6.21	$2.92	$3.77	$4.84	$6.16	$7.12	$8.63	$9.60	$8.86	$13.51	$14.73	$15.70	$15.02	—
Basic Weighted Avg Shares (shares)	53.56M	—	10.66M	9.29M	9.29M	—	9.26M	9.26M	9.24M	—	5.24M	5.04M	5.04M	—	4.30M	4.30M	4.31M	—	2.60M	2.60M	2.60M	—	—

🏦 How resilient is the balance sheet? 2 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$102.93M	$90.37M	$102.48M	$-1.37M	$6.64M	$15.81M	$23.72M	$32.03M	$38.65M	$48.09M	$-6.08M	$-2.00M	$1.37M	$7.10M	$5.08M	$11.61M	$17.91M	$23.74M	—	—	—	$23.39M	—
Total Equity (USD)	$227.25M	$151.49M	$165.07M	$12.02M	$21.41M	$25.97M	$36.90M	$46.12M	$52.82M	$57.30M	$15.26M	$19.72M	$24.40M	$31.06M	$30.62M	$37.12M	$41.26M	$38.55M	$35.08M	$38.26M	$40.77M	$39.01M	$7.69M

📋 What is driving earnings? 4 metrics

Metric	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	—	—	—	—	—	$114.70K	—	$263.14K	$944.58K	$305.01K	$1.27M	$85.52K	$581.10K	$2.16M	$3.59M	$6.35M	$11.80M	$11.06M	$14.68M	$18.21M	$16.93M	—	—
Depreciation Expense (USD)	$730.97K	$741.59K	$700.00K	$800.00K	$756.60K	$764.01K	$900.00K	$1.00M	$1.96M	$922.49K	$960.00K	$870.00K	$898.45K	$898.81K	$885.20K	$749.19K	$636.24K	$619.98K	$369.37K	$258.89K	$235.96K	—	—
Net Income, GAAP (USD)	$-18.87M	$-16.86M	$-5.20M	$-5.20M	$-5.20M	$-11.39M	$-5.03M	$-5.03M	$-5.03M	$-22.86M	$-7.35M	$-7.35M	$-7.35M	$-7.87M	$985.86K	$985.86K	$985.86K	$-11.55M	$1.41M	$1.41M	$1.41M	—	—
Operating Cash Flow (USD)	$-14.27M	$-16.78M	$-13.05M	$-7.15M	$-7.80M	$-9.53M	—	—	$-10.75M	$-13.45M	—	—	$-1.61M	$-1.56M	—	—	$-10.29M	$-4.88M	$3.80M	$-6.39M	$9.45M	—	—

SAB Biotherapeutics, Inc.

Analytical Summary

23-Year Financial Trajectory

Health Breakdown

Statement lens

Benchmark Lens

Percentile Rankings

Peer Comparison

Compare SABS with peers